Analyses of databases revealed that POU2F1 showed higher expression levels in kidney, ovary, and esophageal cancer, which was compared to normal controls, whereas expression of POU2F1 in some brain tumors, bladder cancer, and liposarcoma was reduced [18]. The gene discussed is POU2F1; the disease is esophageal cancer.